Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Bal Pharma Limited, is a listed public company incorporated on 19 May, 1987. It is classified as a public limited company and is located in Bangalore, Karnataka. It's authorized share capital is INR 20.00 cr and the total paid-up capital is INR 15.92 cr.
Bal Pharma Limited's operating revenue range is INR 100 cr - 500 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 12.2% over the previous year. At the same time, it's book networth has increased by 9.98%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR crores. Based on March 2023 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Read more
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Solvency + | |||||
Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Liquidity + | |||||
Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Performance | |||||
Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return + | |||||
Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Efficiency + | |||||
Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital | |||||
Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
HDFC Bank Limited
No. of Loans: 8
Total Amount : 96.3 cr
Canara Bank
No. of Loans: 2
Total Amount : 58.8 cr
SOUTH INDIAN BANK LTD
No. of Loans: 1
Total Amount : 8.3 cr
Small Industries Development Bank of India
No. of Loans: 1
Total Amount : 4.3 cr
STCI FINANCE LIMITED
No. of Loans: 1
Total Amount : 1.1 cr
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Managing Director | Shailesh Siroya
Shareholder
|
00048109 | 20 years |
Director | Jatish Sheth | 00581963 | 4 years |
Director | H S Venkatesh | 01776040 | 4 years |
Director | Nicola Neeladri | 01997936 | 4 years |
Whole-time Director | Virupakshaya Himesh
Shareholder
|
08554422 | 5 years |
Whole-time Director | Chittanand Damodar Kotian
Shareholder
|
09613054 | 2 years |
CFO | Daddanala Venkat Bharath Bhushan | <HIDDEN> | 2 years |
Kmp | Abdul . Basith | <HIDDEN> | 1 years |
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
NOVOSYNTH RESEARCH LABS PRIVATE LIMITED |
Strike Off
|
3.5 L | 1 | Karnataka |
SANJAY GEMS PVT LTD |
Strike Off
|
1.1 L | 1 | Maharashtra |
LEGEND SIROYA INFRASTRUCTURE PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Maharashtra |
KAUNSHYA INVESTMENTS PRIVATE LIMITED |
Active
|
81.0 L | 1 | Karnataka |
SIROYA PROPERTIES & HOLDINGS PRIVATE LIMITED |
Under Process of Striking Off
|
1.0 L | 1 | Karnataka |
BAL RESEARCH FOUNDATION |
Active
|
10.0 L | 1 | Karnataka |
LIFEZEN HEALTHCARE PRIVATE LIMITED |
Active
|
2.0 Cr | 1 | Karnataka |
SIROYA BUILDERS & REAL ESTATES PRIVATE LIMITED |
Under Process of Striking Off
|
1.0 L | 1 | Karnataka |
BASAV CHEM LIMITED |
Amalgamated
|
10.0 L | 1 | Karnataka |
AURUM RESEARCH & ANALYTICAL SOLUTIONS PRIVATE LIMITED |
Active
|
1.0 L | 2 | Karnataka |
GROW INDIA FINANCIAL ADVISORS LLP |
Strike Off
|
1.0 L | 1 | Karnataka |
BALANCE CLINICS LLP |
Active
|
10.0 L | 1 | Karnataka |
GOLDEN DRUGS PRIVATE LIMITED |
Active
|
3.6 Cr | 1 | Karnataka |
MEGANZA PHARMA LLP |
Active
|
50,000.0 | 1 | Karnataka |
SRUSHTI PHARMACEUTICALS PRIVATE LIMITED |
Active
|
6.8 L | 1 | Karnataka |
MRO-TEK REALTY LIMITED |
Active
|
9.3 Cr | 2 | Karnataka |
WILDCRAFT INDIA LIMITED |
Active
|
55.7 Cr | 1 | Karnataka |
ISG NOVASOFT TECHNOLOGIES LIMITED |
Active
|
36.2 Cr | 1 | Karnataka |
RED SUN DIAMONDS IMPEX PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Karnataka |
RED SUN INFORMATION TECHNOLOGIES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Karnataka |
Name | State / Country | Incorporation Year | Paidup Capital |
---|---|---|---|
LIFEZEN HEALTHCARE PRIVATE LIMITED | Karnataka | 2014 | ₹ 2.0 Cr |
BAL RESEARCH FOUNDATION | Karnataka | 2014 | ₹ 10.0 L |
BALANCE CLINICS LLP | India | - | - |
GOLDEN DRUGS PRIVATE LIMITED | Karnataka | 2012 | ₹ 3.6 Cr |
Balance Clinics LLP | India | - | - |
The incorporation date of BAL PHARMA LIMITED is 19 May, 1987
The authorized share capital of BAL PHARMA LIMITED is INR ₹ 20.0 Cr.
The paid-up capital of BAL PHARMA LIMITED is INR ₹ 15.9 Cr.
The registered address of BAL PHARMA LIMITED is 21-22, BOMMASANDRA INDUSTRIAL AREA Bommasandra Industrial Es tate Bangalore South Bangalore Karnataka - 560099
The CIN number of BAL PHARMA LIMITED is L85110KA1987PLC008368.